Burrows Francis's Form 4 filing
Kura Oncology, Inc. (KURA) · filed Jan 28, 2025
- Accession no.
- 0000950170-25-010117
- Filed
- Jan 28, 2025
- Trade date
- Jan 28, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.0K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burrows FrancisCIK 0002051119 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 | Common Stock | SSaleDisposed | −846 | $7.87 | −$6,658.02 | 22,025 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −1,320 | $7.87 | −$10,388.4 | 20,705 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.